High Tech Pharm Statistics

Total Valuation

High Tech Pharm has a market cap or net worth of KRW 142.48 billion. The enterprise value is 147.25 billion.

Market Cap	142.48B
Enterprise Value	147.25B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

High Tech Pharm has 10.63 million shares outstanding. The number of shares has decreased by -33.56% in one year.

Current Share Class	n/a
Shares Outstanding	10.63M
Shares Change (YoY)	-33.56%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.53%
Owned by Institutions (%)	0.17%
Float	5.84M

Valuation Ratios

The trailing PE ratio is 6.52.

PE Ratio	6.52
Forward PE	n/a
PS Ratio	1.16
PB Ratio	1.22
P/TBV Ratio	1.22
P/FCF Ratio	16.36
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.21, with an EV/FCF ratio of 16.90.

EV / Earnings	10.11
EV / Sales	1.81
EV / EBITDA	6.21
EV / EBIT	7.93
EV / FCF	16.90

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.11.

Current Ratio	2.82
Quick Ratio	1.19
Debt / Equity	0.11
Debt / EBITDA	0.53
Debt / FCF	1.45
Interest Coverage	22.28

Financial Efficiency

Return on equity (ROE) is 13.28% and return on invested capital (ROIC) is 9.33%.

Return on Equity (ROE)	13.28%
Return on Assets (ROA)	8.51%
Return on Capital (ROIC)	9.33%
Revenue Per Employee	1.25B
Profits Per Employee	223.97M
Employee Count	65
Asset Turnover	0.60
Inventory Turnover	1.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+47.75%
50-Day Moving Average	14,628.20
200-Day Moving Average	13,953.30
Relative Strength Index (RSI)	40.51
Average Volume (20 Days)	35,225

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, High Tech Pharm had revenue of KRW 81.56 billion and earned 14.56 billion in profits. Earnings per share was 2,055.66.

Revenue	81.56B
Gross Profit	22.00B
Operating Income	18.58B
Pretax Income	18.04B
Net Income	14.56B
EBITDA	23.70B
EBIT	18.58B
Earnings Per Share (EPS)	2,055.66

Full Income Statement

Balance Sheet

The company has 7.91 billion in cash and 12.67 billion in debt, giving a net cash position of -4.76 billion or -448.03 per share.

Cash & Cash Equivalents	7.91B
Total Debt	12.67B
Net Cash	-4.76B
Net Cash Per Share	-448.03
Equity (Book Value)	116.32B
Book Value Per Share	10,940.03
Working Capital	40.44B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.16 billion and capital expenditures -2.45 billion, giving a free cash flow of 8.71 billion.

Operating Cash Flow	11.16B
Capital Expenditures	-2.45B
Free Cash Flow	8.71B
FCF Per Share	819.28

Full Cash Flow Statement

Margins

Gross margin is 26.98%, with operating and profit margins of 22.78% and 17.85%.

Gross Margin	26.98%
Operating Margin	22.78%
Pretax Margin	22.12%
Profit Margin	17.85%
EBITDA Margin	29.06%
EBIT Margin	22.78%
FCF Margin	10.68%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 0.75%.

Dividend Per Share	100.00
Dividend Yield	0.75%
Dividend Growth (YoY)	114.29%
Years of Dividend Growth	2
Payout Ratio	4.87%
Buyback Yield	33.56%
Shareholder Yield	34.30%
Earnings Yield	15.34%
FCF Yield	6.11%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.5

Scores

High Tech Pharm has an Altman Z-Score of 5.55.

Altman Z-Score	5.55
Piotroski F-Score	n/a